Название продукции:6-Methyl-2,3,4,9-tetrahydro-1H-carbazole
IUPAC Name:6-methyl-2,3,4,9-tetrahydro-1H-carbazole
Упаковочная единица | Доступно для заказа | Цена ($) | Количество |
---|
Product Overview |
6-Methyl-2,3,4,9-tetrahydro-1H-carbazole, also known as MTHC, is a heterocyclic compound with a carbazole backbone. |
Synthesis Method |
6-Methyl-2,3,4,9-tetrahydro-1H-carbazole can be synthesized by the Pictet-Spengler reaction, which involves the condensation of an indole or tryptamine with an aldehyde or ketone in the presence of an acid catalyst. |
Chemical Properties |
6-Methyl-2,3,4,9-tetrahydro-1H-carbazole is challenging to synthesize and is unstable under certain conditions, which limits its use in laboratory experiments. |
Synthesis and Application |
6-Methyl-2,3,4,9-tetrahydro-1H-carbazole has been studied for its potential therapeutic applications in the treatment of obesity, depression, and anxiety disorders. In animal models, 6-Methyl-2,3,4,9-tetrahydro-1H-carbazole has been shown to reduce food intake and body weight by activating the 5-HT2C receptor, which regulates satiety and energy balance. 6-Methyl-2,3,4,9-tetrahydro-1H-carbazole has also been shown to have antidepressant and anxiolytic effects by modulating the serotonergic system in the brain. |
Future Directions |
Future directions for research on 6-Methyl-2,3,4,9-tetrahydro-1H-carbazole include the development of more efficient synthesis methods, the investigation of its potential therapeutic applications in humans, and the exploration of its interactions with other neurotransmitter systems. 6-Methyl-2,3,4,9-tetrahydro-1H-carbazole may also have potential applications in the treatment of cognitive disorders such as Alzheimer's disease and schizophrenia. Further research is needed to fully understand the mechanism of action and potential therapeutic benefits of 6-Methyl-2,3,4,9-tetrahydro-1H-carbazole. |